GlassScriptPhysician profile
Elizabeth Jane Thomas
NPI 1356504039
$1,149.36
in general payments reported to CMS, 2019-2025
10 companies · $94.07 in 2025
The $94.07 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.71 · 2022: $168 · 2023: $33.77 · 2024: $840 · 2025: $94.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $746 · Food and Beverage: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $745.66 |
| Food and Beverage | $221.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $745.66 | 2024 | |
| Emd Serono, INC. | $95.10 | 2022 | |
| Pfizer INC. | $75.22 | 2022-2025 | |
| Abbvie INC. | $63.67 | 2021-2022 | |
| Organon LLC | $46.42 | 2024-2025 | Nexplanon |
| Exeltis, USA INC. | $46.30 | 2024-2025 | Slynd |
| Hologic Sales and Service, LLC | $26.78 | 2025 | Fetal Fibronectin Enzyme Immunoassay |
| Biogen, INC. | $20.86 | 2024 | Zurzuvae |
| Astellas Pharma US INC | $15.46 | 2024 | Veozah |
| Minerva Surgical, INC | $13.89 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.